The protein KMP11 is a kinetoplastid membrane protein of 11 kDa. It has been described that the mayority of individuals with Leishmania infection without disease did not have antibodies to KMP11. Therefore serological tests with this recombinant antigen may be helpful as tools to determine therapeutic responses for VL, being the detection of antibodies to KMP11 helpful to differentiate subclinical Leishmania infection from active VL.
FOR RESEARCH AND COMERCIAL USE IVD ONLY (*)
(*) Our antigens are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. For more information about the general features of our antigens, you can visit here.